Clearside Biomedical, Inc. (CLSDQ)
OTCMKTS · Delayed Price · Currency is USD
0.2490
0.00 (0.00%)
Inactive · Last trade price on Jul 13, 2026

Clearside Biomedical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
18727367164132
Market Cap Growth
--1.32%8.31%-58.91%23.85%11.02%
Enterprise Value
65988646140120
Last Close Price
0.2514.2517.5516.8041.2541.10

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PE Ratio
----436.39-
PS Ratio
5.5143.308.8850.805.5516.78
PB Ratio
-0.34-1.85-4.596.364.3215.12
P/TBV Ratio
---6.364.3215.12

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
19.5659.1610.4634.954.7215.16

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
-1.14-1.35-2.703.320.020.23
Net Debt / Equity Ratio
-1.02-0.83-0.88-1.23-0.78-1.75
Net Debt / EBITDA Ratio
-2.42-1.13-0.570.4366.280.86
Net Debt / FCF Ratio
-2.52-1.26-0.710.962.771.16
Asset Turnover
0.160.060.190.030.950.34
Quick Ratio
2.554.284.318.358.721.74
Current Ratio
2.984.444.428.549.081.82
Return on Equity (ROE)
----135.63%1.61%-182.83%
Return on Assets (ROA)
-70.35%-61.04%-36.40%-40.17%-1.26%-48.63%
Return on Capital Employed (ROCE)
-258.80%-142.10%-91.30%-66.50%-1.60%-191.20%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-141.75%-47.68%-44.49%-48.87%0.23%-13.74%
FCF Yield
-118.58%-35.63%-27.27%-20.19%-6.54%-9.94%
Buyback Yield / Dilution
-9.72%-19.41%-2.66%-0.50%-28.81%-21.84%